New Cosmetic Breast Augmentation Risk Awareness Tool for patients to use when considering cosmetic breast implant surgery.
Similar Posts
IXCHIQ Chikungunya vaccine: temporary suspension in people aged 65 years or older
The Commission on Human Medicines (CHM) has temporarily restricted use of the IXCHIQ Chikungunya vaccine in people aged 65 years and over following very rare fatal reactions reported globally. This is a precautionary measure while the MHRA conducts a safety review. The IXCHIQ vaccine will be available on the UK market from 18 June 2025.
Submission and assessment timetables for innovative medicines applications
Guidance on the deadlines for initial and response submissions.
Multi-million pound backing for cutting edge projects by UK scientists and innovators
New government funding will help make the boldest ideas in UK life sciences a reality.
Medicines marketing authorisation: change of ownership
How to change the ownership from one marketing authorisation (MA) holder to another.
Regulation of AI in Healthcare
The MHRA is seeking evidence on the regulation of AI in healthcare to inform the recommendations of the National Commission into the Regulation of AI in Healthcare.
Guidance: Operational Information Sharing
Guidance for Marketing Authorisation (MA) applicants on providing consent to share operational information during the MA application process.